Global Market Research Report on Hemoglobinopathies Market 2016 is a professional and in-depth complete study on the current state of the Hemoglobinopathies worldwide.

Deerfield Beach, FL -- (SBWire) -- 09/06/2016 --Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules, particularly defective globin chains. Hemoglobinopathies are inherited single-gene disorders of which sickle cell disease is the most common kind. There is a high prevalence of Hemoglobinopathies in Africa, Southeast Asia and the Mediterranean basin. If left untreated, critical cases of hemoglobinopathies lead to anemia, organ dysfunction or death. Gel electrophoresis and complete blood count are used as diagnostic tests to determine the presence of hemoglobinopathies.

The disease does not have a permanent cure; this has resulted in a growing demand for new product innovations in the pharmaceutical sector. Additionally, the high prevalence of the disease and the national control program are driving the need for drug therapy in developing economies. Alnylam Pharmaceuticals, Gamilda Cell, Sangamo Biosciences, Cancer Therapeutics CRC Pty Ltd and Biogen Idec are some of the key players in this market. These companies have invested huge sums of money in research and development of hemoglobinopathies to develop a permanent cure for this disease. NiCord, ZFP and ALN-TMP are some of the current products available in the market. Companies have adopted the strategy of collaboration and licensing to supplement their research activities.

Get Free Sample Report Of Hemoglobinopathies Market :http://www.marketresearchstore.com/report/world-hemoglobinopathies-market-opportunities-and-forecasts-2014-68562#RequestSample

Global hemoglobinopathies market is segmented on the basis therapeutics and geography. The therapeutic segment includes various drugs such as NiCord, ZFP Transcription Factors, ALN-TMP, Drug Targeting PRMT5 and Drug Targeting Protein Arginine Methyltransferase 5. ALN-TMP is a subcutaneous RNAi therapeutic that targets Tmprss6 and is used in the treatment of ?-thalassemia. NiCord®, based on the novel NAM technology, is a potential solution for a number of diseases such as thalassemia, sickle cell disease, hematological malignancies, severe rare genetic metabolic diseases and autoimmune diseases. Geographically, the global hemoglobinopathies market is segmented into North America, Europe, Asia-Pacific and LAMEA. Africa is the leading market for these drugs due to the high prevalence of hemoglobinopathies in the region.

KEY BENEFITS

The report provides an overview of the global hemoglobinopathies market, which includes drivers, restraints and opportunities to help professionals better understand market behavior

Detailed information regarding R&D activities, pipeline research, partnerships, licensing and collaborations in the global hemoglobinopathies market would be informative for professionals in the corporate sector

Pin-point analysis of geographic segments would help stakeholders identify opportunities for growth within the global hemoglobinopathies market

Porter's Five Forces analysis examines the competitive structure of the global hemoglobinopathies market and would assist market strategists in their decision making process

Do Inquiry Before Purchasing Report:http://www.marketresearchstore.com/report/world-hemoglobinopathies-market-opportunities-and-forecasts-2014-68562#InquiryForBuying

KEY MARKET SEGMENTS

The global hemoglobinopathies market is segmented into two major categories: pipeline therapeutics and geography.

MARKET BY PIPELINE THERAPEUTICS

NiCord
ZFP Transcription Factors
ALN-TMP
Drug Targeting PRMT5
Drug Targeting Protein Arginine Methyltransferase 5

MARKET BY GEOGRAPHY

North America
Europe
Asia-Pacific
LAMEA

About Market Research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Joel John
3422 SW 15 Street, Suite #8138,
Deerfield Beach, Florida 33442,
United States
Tel: 386-310-3803
GMT Tel: +49-322 210 92714
USA/CanadaToll Free No. 855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/